Literature DB >> 12410741

Benign prostatic hyperplasia: the opposite effects of alcohol and coffee intake.

R Gass1.   

Abstract

OBJECTIVE: To assess several lifestyle factors influencing benign prostatic enlargement and therefore the severity of benign prostatic hyperplasia (BPH). SUBJECTS AND METHODS: In age-stratified cohorts from population-based random samples of 882 men (aged 65, 70, 75 and 80 years) each participant completed a standardized questionnaire, including weight, height, socio-economic status, use of cigarettes, alcohol and coffee consumption. The questionnaire also elicited detailed information on the medical history of prostatic and (over the past month) lower urinary tract symptoms, applying all questions from the American Urology Association instrument. The lifestyle variables were evaluated for confounding by multiple logistic regression, controlling for age, relative weight and professional education, with those classified as having BPH analysed as the dependent variable.
RESULTS: The prevalence of surgery for BPH increased with age from 15% at 65 years to 41% at 80 years. There was a strong inverse association between alcohol intake and men treated surgically for BPH or in 'watchful waiting' for surgical intervention, but a positive correlation with coffee consumption, and although not significantly, with the number of cigarettes smoked. Nevertheless, those who had never smoked have a slightly greater risk of BPH than current smokers. The body mass index and professional education were not associated with the risk of BPH.
CONCLUSIONS: Given the opposite effects of coffee and moderate alcohol consumption, together with the increased risk for clinical BPH in men with coronary heart disease, coffee constituents, which increase the serum concentration of low-density lipoprotein cholesterol, may be involved in the pathophysiology of BPH. Further epidemiological studies are needed to evaluate whether avoiding coffee intake reduces the risk of BPH.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12410741     DOI: 10.1046/j.1464-410x.2002.03001.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  7 in total

1.  Self-management for men with lower urinary tract symptoms.

Authors:  Christian T Brown; Mark Emberton
Journal:  Curr Urol Rep       Date:  2009-07       Impact factor: 3.092

Review 2.  Risk factors for benign prostatic hyperplasia.

Authors:  Steven J Jacobsen
Journal:  Curr Urol Rep       Date:  2007-07       Impact factor: 3.092

Review 3.  Self-management in lower urinary tract symptoms: the next major therapeutic revolution.

Authors:  T L Yap; C T Brown; M Emberton
Journal:  World J Urol       Date:  2006-05-10       Impact factor: 4.226

4.  Evidence of the Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract Symptoms: A Systematic Review.

Authors:  Catherine S Bradley; Bradley A Erickson; Emily E Messersmith; Anne Pelletier-Cameron; H Henry Lai; Karl J Kreder; Claire C Yang; Robert M Merion; Tamara G Bavendam; Ziya Kirkali
Journal:  J Urol       Date:  2017-05-04       Impact factor: 7.450

5.  Chronic caffeine intake increases androgenic stimuli, epithelial cell proliferation and hyperplasia in rat ventral prostate.

Authors:  Carolina Sarobo; Lívia M Lacorte; Marcela Martins; Jaqueline C Rinaldi; Andrei Moroz; Wellerson R Scarano; Flavia K Delella; Sérgio L Felisbino
Journal:  Int J Exp Pathol       Date:  2012-12       Impact factor: 1.925

6.  The study about physical activity for subjects with prevention of benign prostate hyperplasia.

Authors:  Ho Won Lee; Shin Ah Kim; Ji Won Nam; Mi Kyung Kim; Bo Youl Choi; Hong Sang Moon
Journal:  Int Neurourol J       Date:  2014-09-24       Impact factor: 2.835

7.  Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP).

Authors:  Huan Xu; Chong Liu; Meng Gu; Yanbo Chen; Zhikang Cai; Qi Chen; Zhong Wang
Journal:  Oncotarget       Date:  2017-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.